Chethana Medicaments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.54 M
as on 04-07-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 04-07-2024
- Revenue -40.48%
(FY 2021)
- Profit -35.40%
(FY 2021)
- Ebitda 183.76%
(FY 2021)
- Net Worth 37.37%
(FY 2021)
- Total Assets 5.57%
(FY 2021)
About Chethana Medicaments
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.54 M.
The company currently has active open charges totaling ₹2.50 M.
Saraswathy Narayanan, Avanoormana Nambudiri, Damodar Avanoor, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397KL1994PTC007632
- Company No.
007632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chethana Medicaments?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunnakkavu Purushothaman  | Managing Director | 10-Jan-1994 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saraswathy Narayanan | Director | 17-Jun-2019 | Current |
| Avanoormana Nambudiri | Whole-Time Director | 10-Jan-1994 | Current |
| Damodar Avanoor | Whole-Time Director | 10-Jan-1994 | Current |
| Narayanan Mana | Director | 01-Nov-1995 | Current |
Financial Performance of Chethana Medicaments.
Chethana Medicaments Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.48% decrease. The company also saw a substantial fall in profitability, with a 35.4% decrease in profit. The company's net worth Soared by an impressive increase of 37.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chethana Medicaments?
In 2021, Chethana Medicaments had a promoter holding of 59.83% and a public holding of 40.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chethana Formulations Private LimitedActive 31 years 9 monthsAvanoormana Nambudiri, Damodar Avanoor and 1 more are mutual person
Chethana Merchandise Private LimitedActive 28 years 10 monthsDamodar Avanoor and Kunnakkavu Purushothaman are mutual person
- Chelamala Field Latex Producer Company LimitedActive 5 years 7 months
Damodar Avanoor and Narayanan Mana are mutual person
- Chethana Remedies (India) Private LimitedActive 14 years 11 months
Damodar Avanoor is a mutual person
- Sreeparna Pharmaceutical Distributors Private LimitedActive 15 years 5 months
Damodar Avanoor is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhanlaxmi Bank Limited Creation Date: 27 Jul 2020 | ₹0.35 M | Open |
Dhanlaxmi Bank Limited Creation Date: 24 Sep 2018 | ₹2.00 M | Open |
Dhanalakshmi Creation Date: 11 Nov 1995 | ₹0.15 M | Open |
How Many Employees Work at Chethana Medicaments?
Unlock and access historical data on people associated with Chethana Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chethana Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chethana Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
